BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alhaj-Suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Adv Drug Deliv Rev 2022;189:114482. [PMID: 35944587 DOI: 10.1016/j.addr.2022.114482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Alhaj-Suliman SO, Naguib YW, Wafa EI, Saha S, Ebeid K, Meng X, Mohammed HH, Abuo-Rahma GEA, Yang S, Salem AK. A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials 2023;296:122093. [PMID: 36965280 DOI: 10.1016/j.biomaterials.2023.122093] [Reference Citation Analysis]
2 Ferreira MD, Duarte J, Veiga F, Paiva-Santos AC, Pires PC. Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy. Pharmaceutics 2023;15. [PMID: 36840000 DOI: 10.3390/pharmaceutics15020678] [Reference Citation Analysis]
3 Afonin KA, Dokholyan NV. Editorial to "Molecular engineering of biomaterials programmed to operate in living systems". Adv Drug Deliv Rev 2023;193:114669. [PMID: 36529189 DOI: 10.1016/j.addr.2022.114669] [Reference Citation Analysis]
4 Chen J, Cong X. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects. Biomed Pharmacother 2023;157:113998. [PMID: 36399829 DOI: 10.1016/j.biopha.2022.113998] [Reference Citation Analysis]
5 Beretta GL. Nanostrategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0. Int J Mol Sci 2022;23. [PMID: 36430963 DOI: 10.3390/ijms232214486] [Reference Citation Analysis]